Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$240.69 - $338.77 $9,386 - $13,212
-39 Reduced 0.94%
4,099 $991,000
Q2 2023

Aug 14, 2023

SELL
$271.54 - $344.06 $73,315 - $92,896
-270 Reduced 6.13%
4,138 $1.42 Million
Q1 2023

May 15, 2023

BUY
$220.43 - $278.69 $4,629 - $5,852
21 Added 0.48%
4,408 $1.23 Million
Q4 2022

Feb 14, 2023

BUY
$151.88 - $228.5 $666,297 - $1 Million
4,387 New
4,387 $974,000
Q4 2020

Feb 16, 2021

SELL
$174.98 - $272.83 $373,232 - $581,946
-2,133 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$185.27 - $238.73 $38,906 - $50,133
210 Added 10.92%
2,133 $415,000
Q2 2020

Aug 14, 2020

SELL
$153.32 - $191.72 $191,956 - $240,033
-1,252 Reduced 39.43%
1,923 $344,000
Q1 2020

May 15, 2020

SELL
$124.34 - $193.76 $1.23 Million - $1.91 Million
-9,881 Reduced 75.68%
3,175 $512,000
Q4 2019

Feb 14, 2020

BUY
$134.81 - $177.8 $329,475 - $434,543
2,444 Added 23.03%
13,056 $2.15 Million
Q3 2019

Nov 14, 2019

BUY
$131.82 - $183.4 $756,119 - $1.05 Million
5,736 Added 117.64%
10,612 $1.43 Million
Q2 2019

Aug 13, 2019

SELL
$124.65 - $167.39 $5.14 Million - $6.9 Million
-41,218 Reduced 89.42%
4,876 $780,000
Q1 2019

May 17, 2019

BUY
$115.84 - $160.31 $1.64 Million - $2.27 Million
14,163 Added 44.36%
46,094 $6.78 Million
Q4 2018

Feb 14, 2019

BUY
$113.42 - $156.48 $2.03 Million - $2.81 Million
17,936 Added 128.16%
31,931 $3.9 Million
Q3 2018

Oct 30, 2018

BUY
$121.55 - $156.8 $765,035 - $986,899
6,294 Added 81.73%
13,995 $2.1 Million
Q2 2018

Jul 31, 2018

BUY
$112.2 - $165.95 $186,139 - $275,311
1,659 Added 27.46%
7,701 $1.06 Million
Q1 2018

Apr 30, 2018

BUY
$84.6 - $126.1 $511,153 - $761,896
6,042 New
6,042 $699,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.5B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.